Updates are available Correction dated 2023-09-12
Click to view Correction: https://doi.org/10.1186/s44247-023-00045-w
-
Authors
Tulu, Thomas Wetere
Wan, Tsz Kin
Chan, Ching Long
Wu, Chun Hei
Woo, Peter Yat Ming
Tseng, Cee Zhung Steven
Vodencarevic, Asmir
Menni, Cristina
Chan, Kei Hang Katie
-
Funding
Funding for this research was provided by:
Innovation and Technology Fund Public Sector trial Scheme for COVID-19 (SST/141/20GP)
City University of Hong Kong New Research Initiatives/Infrastructure Support from Central (9610401)
- License Information
-
More Information
Article History
Received: 22 May 2022
Accepted: 16 December 2022
First Online: 3 February 2023
Change Date: 14 September 2023
Change Type: Update
Change Details: This article has been corrected since original publication; please see the linked erratum for further details.
Change Date: 12 September 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s44247-023-00045-w
Declarations
:
: The use of clinical data in this study was approved by the human ethics committee of the City University of Hong Kong with a waiver of informed consent, and the study protocol was performed following the Declaration of Helsinki principles.
: Not applicable.
: All Authors declare no Competing Non-Financial Interests and Competing Financial Interests but the following Competing Financial Interests: Asmir Vodencarevic is an employee of Novartis Pharma GmbH.
